Search

everythinglearnresearchcommunity

for

Search:↓

Cytarabine can cause multiple organ toxicities, especially neurotoxicity, but better research methods are needed to fully understand and predict these effects.

Exosomes from platelet-rich plasma may help heal wounds but need more research for hair growth and skin use.

Higher prolactin levels are linked to psoriasis, alopecia areata, and vitiligo severity.

Exosomes from stem cells may help rejuvenate skin and regrow hair, but more research is needed.

IBD treatment is complex and requires personalized approaches due to varying patient responses.

Mesenchymal stem cells and their vesicles may effectively treat skin diseases, but more research is needed.

Stress affects skin health, and mental health support is crucial for patients with skin conditions.

Combining stem cells and organoids could improve skin regeneration treatments.

Mesenchymal stem cells can help repair body tissues with low risk of rejection.

Extracellular vesicles show potential in dermatology, but more research is needed for validation.

Certain cytokines may cause or be affected by immune skin diseases, suggesting possible new treatments.

3D bioprinting shows promise for better skin regeneration by creating structures similar to natural skin.

Chronic inflammation can cause cancer by making stem cells divide and mutate.

CEFFE injections effectively and safely improve postinflammatory hyperpigmentation.

MSM supplementation in kittens improves hair quality and growth rate without harming their health.

Skin bacteria help heal wounds and restore healthy skin.

Albizia saponaria bark extract may help treat hair loss.

Higher levels of certain DNAs in blood may indicate hair follicle damage in alopecia areata patients.

JAK inhibitors show promise in treating difficult skin diseases.

Janus kinase inhibitors may help treat cutaneous T-cell lymphoma, but more research is needed.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

JAK inhibitors do not increase cancer risk in severe alopecia areata compared to traditional treatments.

JAK inhibitors may help treat Alopecia Areata but need careful monitoring due to side effects.

JAK inhibitors effectively reduce alopecia areata symptoms in Black patients.

TYK2 inhibitors show promise for treating cancer and autoimmune disorders.